Homocysteine lowering in end-stage renal disease: is there any cardiovascular benefit?

Circulation. 2010 Mar 30;121(12):1379-81. doi: 10.1161/CIR.0b013e3181daa7c9. Epub 2010 Mar 15.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Homocysteine / blood
  • Homocysteine / drug effects*
  • Humans
  • Kidney Failure, Chronic / complications*
  • Kidney Failure, Chronic / therapy

Substances

  • Homocysteine